AbbVie Completes $63 Billion Allergan Acquisition: Pharmaceutical Industry Consolidates Into Oligopoly

AbbVie completed its $63 billion acquisition of Allergan after FTC approval requiring divestiture of digestive drug brazikumab to resolve antitrust concerns. The merger created a pharmaceutical giant with combined 2019 revenues of $48 billion and a diversified portfolio spanning immunology, …